Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-26 @ 5:56 PM
Study NCT ID:
NCT01958060
Status:
TERMINATED
Last Update Posted:
2015-07-30
First Post:
2013-10-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-01
First Submit QC Date:
None
Study First Post Date:
2013-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-07-02
Results First Submit QC Date:
None
Results First Post Date:
2015-07-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-07-02
Last Update Post Date:
2015-07-30
Last Update Post Date Type:
ESTIMATED